Intravenous lipids in newborn lungs: thromboxane-mediated effects

Area of Science:

• Physiology
• Pharmacology

Background:

• Intravenous lipid infusions are critical in neonatal nutrition but can lead to adverse cardiopulmonary effects.
• Pulmonary hypertension and impaired oxygenation are known complications, potentially mediated by vasoconstrictors like thromboxane (Tx).

Purpose of the Study:

• To investigate the role of thromboxane (Tx) in mediating the effects of intravenous lipid infusions on pulmonary hemodynamics and oxygen transport in newborn piglets.
• To assess the efficacy of a Tx antagonist in mitigating these adverse effects.

Main Methods:

• Newborn piglets received continuous intravenous lipid infusions.
• Cardiopulmonary hemodynamics, blood gases, and oxygen transport parameters were monitored.
• After one hour, piglets were randomized to receive either placebo or the Tx antagonist SQ 29548.

Main Results:

• Intravenous lipid infusion induced pulmonary vasoconstriction and reduced oxygen delivery (DO2) in all piglets.
• Pulmonary artery pressure remained elevated in the placebo group but normalized in the SQ 29548 group.
• TxB2 levels significantly increased with lipid infusion and decreased following Tx antagonism.
• Oxygenation and DO2 improved only in piglets treated with the Tx antagonist.

Conclusions:

• Intravenous lipid infusions in piglets cause pulmonary hypertension and impaired oxygen delivery, associated with increased thromboxane (Tx) production.
• Tx antagonism effectively ameliorates these cardiopulmonary and oxygen transport disturbances.
• These findings highlight Tx as a key mediator in lipid-induced pulmonary vasoconstriction and hypoxemia.